Connecting you with licensed medical providers
GLP-1 medications are prescription drugs regulated by the FDA. Legal access requires evaluation by a licensed clinician. Compare programs, understand costs, and learn what to expect — without the hype.
Prescription treatment is available only when a licensed clinician determines it is appropriate. This page is educational and is not medical advice.
The five questions we hear most — answered directly, without hype.
GLP-1 medications are prescription drugs that mimic a natural gut hormone. They help regulate blood sugar, slow digestion, and reduce appetite. FDA-approved examples include semaglutide and tirzepatide.
Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved for chronic weight management. Ozempic and Mounjaro are approved for type 2 diabetes.
Yes — through licensed telehealth providers that complete medical intake, screening, and clinician review. A prescription is issued only if medically appropriate. No guaranteed approvals exist.
Yes, always. GLP-1 drugs are prescription-only. OTC patches, gummies, or drops marketed as "GLP-1" are not GLP-1 receptor agonists and are not the same thing.
Brand-name can exceed $1,000/month without insurance. Compounded versions may cost less. See our GLP-1 cost guide for a full breakdown of what affects your price.
Find the perfect treatment for real results through a fully licensed, clinical pathway.
Complete a quick health questionnaire covering your medical history, current medications, and weight-loss goals. No commitment required.
A licensed clinician reviews your full case. They determine if a GLP-1 prescription is medically appropriate for you — no guaranteed approvals, no shortcuts.
If prescribed, your medication is sent to a licensed pharmacy — brand-name or compounded depending on the program. Ongoing clinician support is included.
GLP-1 medications have been studied extensively in large clinical trials. Wegovy trials showed meaningful average body weight reduction over 68 weeks. Tirzepatide (Zepbound) trials showed even greater average reductions in separate studies.
Results vary by individual — weight loss depends on medication adherence, lifestyle factors, and your medical picture. A licensed clinician can help set realistic expectations for your situation.
Ozempic and Mounjaro are FDA-approved for type 2 diabetes — not weight loss. Their approval category must be described accurately when considering options with a clinician.
| Brand | Active Ingredient | FDA-Approved Use | Context | Learn More |
|---|---|---|---|---|
Wegovy Novo Nordisk |
Semaglutide | Chronic weight management | Primary weight-loss GLP-1 option | Wegovy guide → |
Zepbound Eli Lilly |
Tirzepatide | Chronic weight management | GIP + GLP-1 dual agonist for weight | Zepbound guide → |
Ozempic Novo Nordisk |
Semaglutide | Type 2 diabetes | Often discussed for weight — not approved for it | Ozempic guide → |
Mounjaro Eli Lilly |
Tirzepatide | Type 2 diabetes | Often discussed for weight — not approved for it | Mounjaro guide → |
Rybelsus Novo Nordisk |
Semaglutide (oral) | Type 2 diabetes | Only oral GLP-1 tablet | Full list → |
Saxenda Novo Nordisk |
Liraglutide | Chronic weight management | Daily injection, older weight GLP-1 | Full list → |
All GLP-1 medications require a prescription from a licensed clinician. Compare these options — your provider will help determine which, if any, is appropriate.
FDA-approved for chronic weight management. Weekly subcutaneous injection. The weight-loss–specific formulation of semaglutide.
FDA-approved for chronic weight management. Weekly injection. Dual GIP + GLP-1 agonist — a newer mechanism with strong clinical trial results.
FDA-approved for type 2 diabetes. Frequently discussed in weight-loss contexts. Clinicians may prescribe off-label — their decision, not ours.
FDA-approved for type 2 diabetes. GIP + GLP-1 dual agonist. Frequently discussed for weight management — clinician evaluation required.
Brand names are registered trademarks of their respective manufacturers. This site is not affiliated with Novo Nordisk or Eli Lilly. All medications require a valid prescription from a licensed clinician.
"The intake process was straightforward and the clinician actually took time to review my full history before prescribing. I appreciated that they didn't just rubber-stamp it."
"I did my consultation with a licensed provider online and it felt just as thorough as an in-person visit. Had my questions answered and knew exactly what to expect."
"This site helped me understand the difference between FDA-approved options and the sketchy stuff I kept seeing online. Worth reading before you make any decisions."
No guesswork. No grey-market risk. Licensed providers connect you to prescription GLP-1 programs designed and managed by real clinicians.
Affiliate disclosure: Partner links may earn a commission.
Program features vary by provider. Verify current inclusions and pricing directly with each program. Prescription issued only if clinically appropriate — no guaranteed approvals.
Photo: Pexels
GLP-1 treatments may support significant weight reduction, but the benefits go beyond the scale — when clinically appropriate and properly supervised.
Clinical trials show meaningful average body weight reduction. Individual results vary and depend on many factors.
Reduced weight is associated with improvements in blood pressure, blood sugar, and cardiovascular risk markers.
GLP-1 medications were originally developed for type 2 diabetes — blood sugar regulation is a primary mechanism of action.
Slowing gastric emptying and appetite signaling helps reduce caloric intake — making dietary changes more manageable.
The GLP-1 category has attracted a wave of misleading products. Understanding the legal landscape protects you.
Wegovy, Zepbound, Ozempic, Mounjaro. Manufactured under FDA oversight. Prescription required from a licensed pharmacy.
Prepared by licensed 503A/503B pharmacies. Not FDA-approved individually. Require a valid prescription. Legality varies by shortage status.
Patches, gummies, drops sold OTC. These are not GLP-1 receptor agonists. Not the same as prescription medications. This site does not promote them.
Unlicensed sellers, peptide powders, no-prescription sources. FDA has warned about dosing errors and contamination. We do not link to these.
FDA-approved semaglutide for weight management
FDA-approved tirzepatide for weight management
Semaglutide for type 2 diabetes
Tirzepatide for type 2 diabetes
Brand vs compounded, insurance, savings programs
What plans cover and what to ask
GI effects, warnings, and what to watch for
Who may qualify for GLP-1 medication
What compounded medications are and aren't
Licensed telehealth providers side by side
How to access Wegovy via telehealth
How to access Zepbound via telehealth
Online GLP-1 providers complete medical screening and clinician review before prescribing. Compare programs, costs, medication options, and requirements — before choosing a path.
Compare online GLP-1 programs →Medical Disclaimer: This content is for educational purposes only and is not medical advice. This page does not constitute a doctor-patient relationship. Talk with a licensed clinician before starting, stopping, or changing any medication. Individual eligibility for prescription medications is determined by a licensed clinician based on a complete medical evaluation.
Affiliate Disclosure: glp1medications.org may receive compensation when you click on or purchase through provider links. This does not influence our educational content. We only link to licensed telehealth providers offering legal, prescription-based GLP-1 pathways.
GLP-1 medications including Wegovy, Zepbound, Ozempic, and Mounjaro are prescription drugs regulated by the FDA. This site is not a pharmacy and does not sell, prescribe, or dispense any medications. Medical reviewer: pending. Last reviewed: May 2026.